(Q48567269)

12 February 2018

title

Interaction of dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system. (English)

1 reference

12 February 2018

1 reference

S Striem

1

1 reference

12 February 2018

A Bar-Joseph

series ordinal

2

1 reference

12 February 2018

Y Berkovitch

series ordinal

3

1 reference

12 February 2018

A Biegon

series ordinal

4

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

12 February 2018

European Journal of Pharmacology

published in

1 reference

12 February 2018

volume

338

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

205-213

1 reference

12 February 2018

Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Molecular cloning and expression of the gene for a human D1 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

A novel probe for the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Kainyl-bovine serum albumin: a novel ligand of the kainate sub-type of glutamate receptor with a very high binding affinity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Chronic treatment with MK-801 decreases D2 dopamine receptor function in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Dopamine Receptors in the Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Excitatory amino acid neurotoxicity and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

A radical hypothesis for neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

2 Cellular responsiveness to hormones and neutrotransmitters: Conversion of 3HAdenine to 3HcAMP in cell monolayers, cell suspensions, and tissue slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Adrenergic alpha- and beta-receptors expressed by the same cell type in primary culture of perinatal mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

Development of HU-211 as a neuroprotectant for ischemic brain damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

inferred from DOI database lookup

7 January 2021

based on heuristic

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Elevated NMDA receptors in parkinsonian striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981923-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(97)81923-1

1 reference

12 February 2018

PubMed ID

9424014

1 reference

12 February 2018